The largest database of trusted experimental protocols

Vimentin

Manufactured by Novus Biologicals
Sourced in United States

Vimentin is a type III intermediate filament protein that is widely expressed in various cell types, particularly in mesenchymal cells. It is a structural protein that plays a key role in maintaining the integrity and shape of cells. Vimentin is often used as a marker for mesenchymal cells and is commonly employed in immunohistochemical and immunocytochemical applications.

Automatically generated - may contain errors

14 protocols using vimentin

1

Characterization of Cell Morphology and Surface Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell morphology and surface protein expression of the two types of cells were compared. Morphologic observations of the third passage dADSCs and VFFs were made using an inverted microscope. The cell surface protein expression levels were identified by cell immunofluorescence.
When the cells reached 80% to 90% confluence, they were fixed in ice-cold 4% paraformaldehyde for 10 minutes and rinsed with phosphate-buffered saline (PBS). They were permeabilized in PBS containing 0.3% Triton X-100 for 30 minutes at room temperature (RT). All cells were blocked (3% horse serum in PBS, 30 minutes, RT) and incubated for 2 hours (4°C) with the following primary antibodies: vimentin (monoclonal mouse vimentin, 1∶200; Novus, Littleton, CO, USA) and fibronectin (polyclonal rabbit fibronectin, 1∶100; Abcam, Cambridge, MA, USA). After a thorough washing, the cells were incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (1∶400; Molecular Probes, Eugene, OR, USA) and 594-conjugated goat anti-mouse IgG (1∶400; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 1 hour (RT). All slides were counterstained using Hoechst 33342 (1∶1000; Roche; 10 minutes, RT) for nuclear staining.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Retinal Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections were incubated with antibodies against ICAM-1 (eBiosciences, San Diego, CA), CXCL1 (Novus, Littleton, CO), NOS2 (EMD Millipore, Burlington, MA), vimentin (Novus), CRALBP (Proteintech Group, Rosemont, IL), β-III tubulin (BioLegend) or MPO (Agilent, Santa Clara, CA) followed by incubation with fluorescent secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Sections were also incubated with Tomato lectin (Vector Laboratories, Burlingame, CA) or ApopTag Red, In situ Apoptosis Detection kit (EMD Millipore, Billerica, MA, USA). Frozen sections were used when examining expression of Alexa Fluor 488-conjugated peptide. Retinas were analyzed using Olympus FV1200 IX-83 confocal microscope. Images were processed in Photoshop CC 19.1.1. using similar linear adjustments for all samples.
+ Open protocol
+ Expand
3

TGFβ and GSK-J4 Regulation of Epithelial-Mesenchymal Transition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were grown on 6-well plates at a seeding density of 2.5 × 10⁵ cells per well. These cells were starved in serum-free RPMI-1640 for 24 h. They were then treated with 5 ng/mL TGFβ and 20 µM GSK-J4, both individually and in combination. After 48 h of treatment, the cells were scraped in RIPA lysis buffer for protein extraction. Protein concentration was estimated using the Bradford assay. SDS-PAGE and Western blot were carried out as per standard protocol. Primary antibodies used were p-SMAD3 (Santa Cruz, Dallas, TX, USA), N-cadherin (Novus, St. Louis, MO, USA), vimentin (Novus, St. Louis, MO, USA), H3 (Invitrogen, Waltham, MA, USA), H3K9me3 (Santa Cruz, Dallas, TX, USA), H3K4me3 (Invitrogen, Waltham, MA, USA), H2K27me3 (Abcam, Cambridge, UK), and actin (Invitrogen, Waltham, MA, USA), and the secondary antibodies were Chicken Anti-Mouse IgG H&L (HRP) (Abcam, Cambridge, UK) and Chicken Anti-Rabbit IgG H&L (HRP) (Abcam, Cambridge, UK). The blot was developed using an ECL reagent (Thermo Scientific SuperSignal West Femto Maximum Sensitivity Substrate, Waltham, MA, USA). The experiment was repeated thrice. The statistical analysis was carried out using ImageJ 1.52a software. The student’s t-test was carried out to calculate significance using GraphPad Prism 9.5.0 software.
+ Open protocol
+ Expand
4

Epithelial Mesenchymal Transition Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
E-cadherin (BD Transduction Labs, 610182; used for immunoblotting), E-cadherin (Zymed, 13-1900; used for immunofluorescence stainings), N-cadherin (Takara, M142), Zona Occludens-1 (Zymed, 617300), Paxillin (BD, 610052), Fibronectin1 (Sigma-Aldrich, F3648), Vimentin (Novus Biological, NB300–223), α-Tubulin (Sigma, T-9026), GAPDH (Abcam, ab9485), Alexa-Fluor 488 and 568 (Molecular Probes), secondary horse radish peroxidase (HRP)-conjugated antibodies against mouse and rabbit (Jackson ImmunoResearch), Phalloidin Alexa-Fluor 568 (Molecular Probes, A12380), 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, D9542), recombinant human TGFβ1 (R&D Systems, 240-B).
+ Open protocol
+ Expand
5

Immunoblotting and Immunohistochemistry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All general chemicals, unless noted, were from Thermo Fisher Scientific (Waltham, MA). Antibodies used for immunoblotting: anti-Cx43, Cx43NT1 made at the Fred Hutchinson Cancer Research Center Antibody Technology Facility (Seattle, WA); E-cadherin, #3195 Cell Signaling Technology (Danvers, MA); NDRG1, Vimentin, #13901 Cell Signaling Technology; Vinculin V4505 MillliporeSigma (Burlington, MA); Immunohistochemistry: Cx43 (6219, MilliporeSigma); Ki67 (12202 Cell Signaling Technology), Progesterone receptor (Lab Vision SP2, Thermo Fisher), Vimentin (Novus Biologicals, Centennial, CO); Immunofluorescence: anti-PCNA (NA03, MilliporeSigma), CK19 (TROMA-3 Developmental Studies Hybridoma Bank (Iowa City, IA)), smooth muscle actin (A5228 MiliporeSigma). Secondary antibodies from ThermoFisher: Rat IgG 647 (A21247); anti-rabbit IgG 594 (A32754); anti-mouse IgG2a 488 (A32723).
+ Open protocol
+ Expand
6

3D Cell Culture Assay Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wells of 8-well chamber slides were coated with 40 μl of TMG (2 mg/ml), Col I (2 mg/ml), or Matrigel (5 mg/ml), and the gels were polymerized in a 37 °C incubator. MM231, MM468, T47D, BT474, or SKBR3 cells were suspended in 400 μl of 1× DMEM containing 2% hydrogel, seeded on top of the polymerized gel (6000 cells/well), and cultured for 5–7 days. The cells were probed with primary antibodies against E-cadherin (Santa Cruz Biotechnology), Vimentin (Novus Biologicals), and ZO-1 (Thermo Fisher Scientific), followed by fluorophore-conjugated secondary antibody and Hoechst staining, and imaged under a fluorescence microscope.
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of Cell Adhesion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
After sacrifice, control and plasma tumor sample tissues were fixed in formalin for the preparation of paraffin sections. Paraffin-embedded tissue sections were deparaffinized in xylene, 95, 90 and 70% ethanol, followed by PBS. Tissue sections were immunostained overnight at 4 °C with the E-cadherin antibody (1:400; abcam, Cambridge, UK), N-cadherin (1:400; abcam) antibody. After PBS washing, 1:200 dilution of biotinylated goat anti-mouse IgG antibody in blocking solution was applied to the sections and incubated for 30–40 min. Following with PBS, ABC reagent was applied to the sections and incubated further for 30 min. Color reaction was performed with 3, 30-diaminobenzidine (vector laboratories, Seoul, Korea) and slides were washed twice with PBS. After counter-staining with hematoxylin and clearing with graded ethanol series and xylene, sections were mounted with Canada balsam. Images were photographed using IX71 microscope (Olympus, Tokyo, Japan) equipped with DP71 digital imaging system (Olympus). For immunohistochemistry, E-cadherin (ab15148), N-cadherin (ab18203), Vimentin (ab137321), CD86 antibody (NBP2-25208-novus biologicals, Centennial, CO, USA) were used.
+ Open protocol
+ Expand
8

Immunoblotting and Immunohistochemistry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All general chemicals, unless noted, were from Thermo Fisher Scientific (Waltham, MA). Antibodies used for immunoblotting: anti-Cx43, Cx43NT1 made at the Fred Hutchinson Cancer Research Center Antibody Technology Facility (Seattle, WA); E-cadherin, #3195 Cell Signaling Technology (Danvers, MA); NDRG1, Vimentin, #13901 Cell Signaling Technology; Vinculin V4505 MillliporeSigma (Burlington, MA); Immunohistochemistry: Cx43 (6219, MilliporeSigma); Ki67 (12202 Cell Signaling Technology), Progesterone receptor (Lab Vision SP2, Thermo Fisher), Vimentin (Novus Biologicals, Centennial, CO); Immunofluorescence: anti-PCNA (NA03, MilliporeSigma), CK19 (TROMA-3 Developmental Studies Hybridoma Bank (Iowa City, IA)), smooth muscle actin (A5228 MiliporeSigma). Secondary antibodies from ThermoFisher: Rat IgG 647 (A21247); anti-rabbit IgG 594 (A32754); anti-mouse IgG2a 488 (A32723).
+ Open protocol
+ Expand
9

Quantifying Protein-Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three independent MST experiments were performed with His-tagged BspC labelled using the Monolith His-Tag Labeling Kit RED-tris-NTA 2nd Generation (NanoTemper Technologies) according to manufacturer’s instructions. The concentration of labelled BspC was kept constant at 10nM. Vimentin was purchased from Novus Biologicals and titrated in 1:1 dilutions to obtain a series of 16 titrations ranging in concentration from 20 μM to 0 μM. Measurements were performed in standard capillaries with a Monolith NT.115 Pico system at 20% excitation power and 40% MST power (NanoTemper Technologies).
+ Open protocol
+ Expand
10

Immunoblotting and Immunofluorescence Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting 2 (link) and immunofluorescence 3 (link) were performed as previously described. Primary antibodies were as follows: β-actin (Sigma, St Louis, MO, USA; A3853), mouse anti-human FOXC2 and rat anti-mouse FOXC2 that also cross-reacts with human FOXC2 (both developed by Dr. Naoyuki Miura, Hamamatsu University School of Medicine, Japan), p-p38 (Cell Signaling, Danvers, MA, USA; 4511), p38 (Cell Signaling; 9211), E-cadherin (BD Biosciences, San Jose, CA, USA; 61081), fibronectin (BD Biosciences; 610077), vimentin (Novus Biologicals, Littleton, CO, USA; NB200-623), ZEB1 (Novus Biologicals; NBP1-05987), and HA (Covance, Princeton, NJ, USA; MMS-101P).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!